Details of the Drug

General Information of Drug (ID: DMKYJJC)

• Drug Name: Tigatuzumab

Indication

Disease Entry	ICD 11	Status	REF
Breast cancer	2C60-2C65	Phase 2	[1]
Colorectal cancer	2B91.Z	Phase 2	[1]
Liver cancer	2C12	Phase 2	[1]
Ovarian cancer	2C73	Phase 2	[1]
Pancreatic cancer	2C10	Phase 2	[1]

• Drug Type: Monoclonal antibody
• Cross-matching ID:
  UNII: 237GB6IDKO
  DrugBank ID: DB15101
  TTD ID: D03LTO
• Drug-Molecule Activity Atlas (DMA)NEW: Click to Jump to the Detailed DMA Information of This Drug
• Repurposed Drugs (RPD): Click to Jump to the Detailed RPD Information of This Drug

References

• [1] ClinicalTrials.gov (NCT01307891) Abraxane With or Without Tigatuzumab in Patients With Metastatic, Triple Negative Breast Cancer. U.S. National Institutes of Health.